10x Genomics (TXG) Change in Acquisitions & Divestments (2022 - 2026)

10x Genomics' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $25.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $25.0 million; the TTM figure through Mar 2026 stood at $25.0 million (down 0.85% YoY), while the FY2024 annual figure was $25.8 million, down 74.27% from the prior year.
• Change in Acquisitions & Divestments came in at $25.0 million for Q1 2026 at 10x Genomics, up from -$100.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $100.0 million in Q3 2025 to a low of -$100.0 million in Q4 2025.
• A 5-year average of $13.3 million and a median of $21.9 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments surged 1884.63% in 2023 and tumbled 556.08% in 2025, its largest moves.
• 10x Genomics' Change in Acquisitions & Divestments stood at $7.7 million in 2022, then surged by 286.99% to $29.9 million in 2023, then decreased by 26.57% to $21.9 million in 2024, then sank by 556.08% to -$100.0 million in 2025, then surged by 125.0% to $25.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $25.0 million, -$100.0 million, and $100.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison